108 related articles for article (PubMed ID: 30606641)
1. Familial hypercholesterolemia and young patients' thoughts on own condition and treatment.
Urke EB; Søbye S; Ellingvåg A; Langslet G; Retterstøl K; Wandel M
Patient Educ Couns; 2019 May; 102(5):1005-1012. PubMed ID: 30606641
[TBL] [Abstract][Full Text] [Related]
2. Patients' understandings and experiences of familial hypercholesterolemia.
Weiner K; Durrington PN
Community Genet; 2008; 11(5):273-82. PubMed ID: 18493125
[TBL] [Abstract][Full Text] [Related]
3. Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study.
Frich JC; Ose L; Malterud K; Fugelli P
Ann Fam Med; 2006; 4(3):198-204. PubMed ID: 16735520
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular-risk patients' experienced benefits and unfulfilled expectations from preventive consultations: a qualitative study.
Kehler D; Christensen B; Lauritzen T; Christensen MB; Edwards A; Bech Risør M
Qual Prim Care; 2008; 16(5):315-25. PubMed ID: 18973712
[TBL] [Abstract][Full Text] [Related]
5. Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
Horter S; Stringer B; Greig J; Amangeldiev A; Tillashaikhov MN; Parpieva N; Tigay Z; du Cros P
BMC Infect Dis; 2016 Jul; 16():362. PubMed ID: 27465783
[TBL] [Abstract][Full Text] [Related]
6. Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia.
Jones LK; Kulchak Rahm A; Manickam K; Butry L; Lazzeri A; Corcoran T; Komar D; Josyula NS; Pendergrass SA; Sturm AC; Murray MF
Circ Genom Precis Med; 2018 Aug; 11(8):e002146. PubMed ID: 30354341
[TBL] [Abstract][Full Text] [Related]
7. Communicating familial hypercholesterolemia genetic information within families.
Maxwell SJ; Molster CM; Poke SJ; O'Leary P
Genet Test Mol Biomarkers; 2009 Jun; 13(3):301-6. PubMed ID: 19473077
[TBL] [Abstract][Full Text] [Related]
8. Meaning of quality of life among patients with familial hypercholesterolemia.
Hollman G; Ek AC; Olsson AG; Berterö C
J Cardiovasc Nurs; 2004; 19(4):243-50. PubMed ID: 15326980
[TBL] [Abstract][Full Text] [Related]
9. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
[TBL] [Abstract][Full Text] [Related]
10. [Familial combined hyperlipidemia: consensus document].
Mata P; Alonso R; Ruíz-Garcia A; Díaz-Díaz JL; González N; Gijón-Conde T; Martínez-Faedo C; Morón I; Arranz E; Aguado R; Argueso R; Perez de Isla L
Semergen; 2014 Oct; 40(7):374-80. PubMed ID: 25131181
[TBL] [Abstract][Full Text] [Related]
11. My Approach to the Patient With Familial Hypercholesterolemia.
Safarova MS; Kullo IJ
Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological performance of young familial hypercholesterolemia patients.
Ariza M; Cuenca N; Mauri M; Jurado MA; Garolera M
Eur J Intern Med; 2016 Oct; 34():e29-e31. PubMed ID: 27264249
[No Abstract] [Full Text] [Related]
13. FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY; Kuri-García A; Ríos-Ríos M; Vargas-Vázquez A; Cortés-Arroyo JE; Tapia-González G; Cruz-Bautista I; Aguilar-Salinas CA
Rev Invest Clin; 2018; 70(5):224-236. PubMed ID: 30307446
[TBL] [Abstract][Full Text] [Related]
14. Participants' willingness to consume soy foods for lowering cholesterol and receive counselling on cardiovascular disease by nutrition professionals.
Schryver T; Smith C
Public Health Nutr; 2006 Oct; 9(7):866-74. PubMed ID: 17010252
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors.
Orsó E; Ahrens N; Kilalić D; Schmitz G
Atheroscler Suppl; 2009 Dec; 10(5):74-8. PubMed ID: 20129380
[TBL] [Abstract][Full Text] [Related]
16. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
[TBL] [Abstract][Full Text] [Related]
17. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia.
Hagger MS; Hardcastle SJ; Hu M; Kwok S; Lin J; Nawawi HM; Pang J; Santos RD; Soran H; Su TC; Tomlinson B; Watts GF
Atherosclerosis; 2018 Oct; 277():493-501. PubMed ID: 30270090
[TBL] [Abstract][Full Text] [Related]
18. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
19. Predicting cardiovascular disease in familial hypercholesterolemia.
Paquette M; Baass A
Curr Opin Lipidol; 2018 Aug; 29(4):299-306. PubMed ID: 29708923
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
